Location
United States, North America
Cheque size
$125K - $15M
Investment Stage
Seed
Series A
Series B
Focus Areas
SaaS
AI
E-commerce
Marketplaces
Health IT
Cloud Infrastructure
Enterprise
Analytics
Social Networks
Food and Beverage
About Investor
Ben Freeberg is the Founder and Managing Partner of Oncology Ventures, a seed-stage fund focused on startups improving cancer care through data, not drug discovery. He typically invests at Seed, backing companies tackling problems from early detection to choosing optimal treatment plans, and he writes checks in the $250,000 to $1.5 million range. Before launching Oncology Ventures, he worked in venture and healthcare, including roles at Optum Ventures and Thyme Care, and he previously spent time at Alpha Partners.
Previous investments
Daymark Health
12M |2025
mPath Health
1M |2024
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.